Abstract:There have been no previous reports of hippocampal radiomics features associated with biological functions in Alzheimer's Disease (AD). This study aims to develop and validate a hippocampal radiomics model from structural magnetic resonance imaging (MRI) data for identifying patients with AD, and to explore the mechanism underlying the developed radiomics model using peripheral blood gene expression. In this retrospective multi-study, a radiomics model was developed based on the radiomics discovery group ( n = 420) and validated in other cohorts. The biological functions underlying the model were identified in the radiogenomic analysis group using paired MRI and peripheral blood transcriptome analyses ( n = 266). Mediation analysis and external validation were applied to further validate the key module and hub genes. A 12 radiomics features-based prediction model was constructed and this model showed highly robust predictive power for identifying AD patients in the validation and other three cohorts. Using radiogenomics mapping, myeloid leukocyte and neutrophil activation were enriched, and six hub genes were identified from the key module, which showed the highest correlation with the radiomics model. The correlation between hub genes and cognitive ability was confirmed using the external validation set of the AddneuroMed dataset. Mediation analysis revealed that the hippocampal radiomics model mediated the association between blood gene expression and cognitive ability. The hippocampal radiomics model can accurately identify patients with AD, while the predictive radiomics model may be driven by neutrophil-related biological pathways.

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper aims to develop and validate a radiomics model of the hippocampus region based on structural magnetic resonance imaging (MRI) data for identifying Alzheimer's disease (AD) patients and exploring the biological mechanisms related to this radiomics model. Specifically, the research objectives include: 1. **Developing the radiomics model**: - Based on the radiomics features of the hippocampus region, develop a prediction model that can distinguish AD patients from normal controls (NC). - Use multi - center data to validate the model to ensure its stability and robustness. 2. **Exploring biological mechanisms**: - Through peripheral blood gene expression analysis, reveal the biological functions behind the radiomics model. - Use weighted gene co - expression network analysis (WGCNA) to identify the gene modules most related to the radiomics features. - Through mediation analysis, explore the mediating role of hippocampus radiomics features between blood gene expression and cognitive ability. ### Research background Alzheimer's disease (AD) is a progressive age - related neurodegenerative disease, mainly manifested as cognitive dysfunction and is the main cause of dementia. Although the pathogenesis of AD is not fully understood, hippocampal atrophy is considered an important sign of AD. Traditional MRI can visually show the changes in brain tissue structure, but these changes can only roughly reflect the complex anatomical changes in AD. Therefore, new methods and techniques are needed to detect more subtle changes in the hippocampus region. ### Research methods 1. **Data sources**: - Obtain data from multiple databases, including ADNI, OASIS, and the data from the author's medical center. - The data are divided into four cohorts: radiomics discovery cohort, radiogenomics analysis cohort, radiomics validation cohort 1, and radiomics validation cohort 2. 2. **Radiomics feature extraction**: - Use a deep - learning - based segmentation model to automatically delineate the hippocampus region. - Extract 214 radiomics features, including shape, intensity, and texture features. 3. **Radiomics model construction and validation**: - Use the minimum redundancy maximum relevance (mRMR) and the least absolute shrinkage and selection operator (LASSO) algorithms to select the most discriminative features. - Construct a multivariate logistic regression model to generate a radiomics score (Radscore). - Evaluate the predictive performance of the model through receiver operating characteristic curve (ROC) analysis. 4. **Gene co - expression module construction and radiogenomics analysis**: - Use WGCNA to construct a gene co - expression network and identify the gene modules most related to the radiomics features. - Conduct gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses to reveal potential biological functions. 5. **Mediation analysis**: - Explore the mediating role of hippocampus radiomics features between blood gene expression and cognitive ability. ### Main findings 1. **Predictive performance of the radiomics model**: - The Radscore based on 12 hippocampus radiomics features showed excellent predictive performance in both the training cohort and the validation cohort, with AUC values of 0.91 and 0.91 respectively. - In the other three independent cohorts, the model also showed strong discriminatory ability, with AUC values of 0.93, 0.91, and 0.87 respectively. 2. **Biological mechanisms**: - Through radiogenomics mapping, it was found that myeloid leukocyte and neutrophil activation were significantly related to hippocampus radiomics features. - Six key genes (TMBIM6, IL1R2, LTB4R, MMP9, PADI4, PRKCD) were identified, which were highly correlated with radiomics features and related to cognitive decline. 3. **Mediation analysis results**: - The hippocampus radiomics features play a mediating role between blood gene expression and cognitive ability, further confirming the importance of radiomics features as an intermediate phenotype. ### Conclusion This study successfully developed a prediction model based on hippocampus radiomics features, which can accurately identify AD patients and revealed the biological mechanisms related to this model. The research results emphasize the important role of neutrophils in the development of AD and provide new methods for the early diagnosis and treatment of AD.

A multi-cohort study of the hippocampal radiomics model and its associated biological changes in Alzheimer's Disease

Independent and Reproducible Hippocampal Radiomic Biomarkers for Multisite Alzheimer's Disease: Diagnosis, Longitudinal Progress and Biological Basis

Multiparametric hippocampal signatures for early diagnosis of Alzheimer's disease using 18F-FDG PET/MRI Radiomics

A Novel Cascade Machine Learning Pipeline for Alzheimer’s Disease Identification and Prediction

Radiomic Features of Hippocampal Subregions in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment

Radiomics Analysis of Magnetic Resonance Imaging Facilitates the Identification of Preclinical Alzheimer’s Disease: An Exploratory Study

Radiomic Study for the Diagnosis of Alzheimer's Disease Based on the Structure Anomaly of Hippocampus

Innovative Multivariable Model Combining MRI Radiomics and Plasma Indexes Predicts Alzheimer's Disease Conversion: Evidence from a 2-Cohort Longitudinal Study

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer's Disease.

Independent and Reproducible Hippocampal Radiomics Biomarkers for Multisite Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.

Radiomics Models Identifying Dementia in Patients with Normal Age-Related Hippocampal Atrophy: A study based on Machine Learning

Quantitative Radiomic Features As New Biomarkers for Alzheimer's Disease: an Amyloid PET Study.

Radiomics: a novel feature extraction method for brain neuron degeneration disease using 18 F-FDG PET imaging and its implementation for Alzheimer's disease and mild cognitive impairment.

Radiomics features as predictors to distinguish fast and slow progression of Mild Cognitive Impairment to Alzheimer's disease

Quantitative Radiomic Features as New Biomarkers for Alzheimer’s Disease: An Amyloid PET Study

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment

Using Deep Learning Radiomics to Distinguish Cognitively Normal Adults at Risk of Alzheimer’s Disease from Normal Control: an Exploratory Study Based on Structural MRI

MRI radiomics combined with machine learning for diagnosing mild cognitive impairment: a focus on the cerebellar gray and white matter

Prediction of Cognitive Progression in Individuals with Mild Cognitive Impairment Using Radiomics as an Improvement of the ATN System: A Five-Year Follow-Up Study

MRI Radiomics Nomogram for Predicting Disease Transition Time and Risk Stratification in Preclinical Alzheimer's Disease

Radiomics evaluation for the early detection of Alzheimer's dementia using T1-weighted MRI